1 Charidimou A, Gang Q, Wer ring DJ. Sporadic

cerebral amyloid angiopathy revisited:recent insights

into pathophysiology and clinical spectrum[J]. J

Neurol Neurosurg Psychiatry, 2012, 83:124-137.

2 Yamada M. Cerebral amyloid angiopathy:emerging

concepts[J]. J Stroke, 2015, 17:17-30.

3 Love S, Miners S, Palmer J, et al. Insights into the

pathogenesis and pathogenicity of cerebral amyloid

angiopathy[J]. Front Biosci (Landmark Ed), 2009,

14:4778-4792.

4 Esiri MM, WilcockGK. Cerebral amyloid angiopathy

in dementia and old age[J]. J Neurol Neurosurg

Psychiatry, 1986, 49:1221-1226.

5 Carare RO, Bernardes-Silva M, Newman TA, et

al. Solutes, but not cells, drain from the brain

parenchyma along basement membranes of capillaries

and ar teries:signif icance for cerebral amyloid

angiopathy and neuroimmunology[J]. Neuropathol

Appl Neurobiol, 2008, 34:131-144.

6 Weller RO, Djuanda E, Yow HY, et al. Lymphatic

drainage of the brain and the pathophysiology of

neurological disease[J]. Acta Neuropathol, 2009,

117:1-14.

7 Sudlow C, Martínez González NA, Kim J, et al.

Does apolipoprotein E genotype influence the risk

of ischemic stroke, intracerebral hemorrhage, or

subarachnoid hemorrhage? Systematic review and

meta-analyses of 31 studies among 5961 cases and

17 965 controls[J]. Stroke, 2006, 37:364-370.

8 Brouwers HB, Bif f i A, McNamara KA, et al.

Apolipoprotein E genotype is associated with

CT angiography spot sign in lobar intracerebral

hemorrhage[J]. Stroke, 2012, 43:2120-2125.

9 O'Donnell HC, Rosand J, Knudsen KA, et al.

Apolipoprotein E genotype and the risk of recurrent

lobar intracerebral hemorrhage[J]. N Engl J Med,

2000, 342:240-245.

10 Leclercq PD, Murray LS, Smith C, et al. Cerebral

amyloid angiopathy in t raumatic brain injury:

association with apolipoprotein E genotype[J]. J Neurol

Neurosurg Psychiatry, 2005, 76:229-233.

11 Yamada M, Naiki H. Cerebral amyloid angiopathy[J].

Prog Mol Biol Transl Sci, 2012, 107:41-78.

12 Arima H, Tzourio C, Anderson C, et al. Effects

of perindopril-based lowering of blood pressure

on intracerebral hemorrhage related to amyloidangiopathy:the PROGRESS trial[J]. Stroke, 2010,

41:394-396.

13 Vonsattel JP, Myers RH, Hedly-Whyte ET, et al.

Cerebral amyloid angiopathy without and with

cerebral hemorrhages:a comparative histological

study[J]. Ann Neurol, 1991, 30:637-649.

14 Mc Car ron MO, Nicoll JA. Cerebral amyloid

angiopathy and thrombolysis-related intracerebral

haemorrhage[J]. Lancet Neurol, 2004, 3:484-492.

15 Vernooij MW, Haag MD, van der Lugt A, et al. Use

of antithrombotic drugs and the presence of cerebral

microbleeds:the Rotterdam Scan Study[J]. Arch

Neurol, 2009, 66:714-720.

16 Thoonsen H, Richard E, Bentham P, et al. Aspirin in

Alzheimer's disease:increased risk of intracerebral

hemorrhage:cause for concern?[J]. Stroke, 2010,

41:2690-2692.

17 王延江. 阿尔茨海默病的免疫治疗:进展、问题与展望

[J]. 中国医学前沿杂志, 2012, 4:13-16.

18 Schenk D, Barbour R, Dunn W, et al. Immunization

with amyloid-beta attenuates Alzheimer-diseaselike

pathology in the PDAPP mouse[J]. Nature, 1999,

400:173-177.

19 Holmes C, Boche D, Wilkinson D, et al. Long-term

effects of Abeta42 immunisation in Alzheimer's

disease:follow-up of a randomised, placebo-controlled

phase I trial[J]. Lancet, 2008, 372:216-223.

20 Boche D, Zotova E, Weller RO, et al. Consequence

of Abeta immunization on the vasculature of human

Alzheimer's disease brain[J]. Brain, 2008, 131:3299-

3310.

21 Thakker DR, Weatherspoon MR, Harrison J, et al.

Intracerebroventricular amyloid-beta antibodies

reduce cerebral amyloid angiopathy and associated

micro-hemorrhages in aged Tg2576 mice[J]. Proc Natl

Acad Sci USA, 2009, 106:4501-4506.

22 Prada CM, Garcia-Alloza M, Betensky RA, et

al. Antibody-mediated clearance of amyloid-beta

peptide from cerebral amyloid angiopathy revealed

by quantitative in vivo imaging[J]. J Neurosci, 2007,

27:1973-1980.

23 Li f sh i t z V, We i s s R , B en roma no T, e t a l .

Immunotherapy of cerebrovascular amyloidosis in a

transgenic mouse model[J]. Neurobiol Aging, 2012,

33:432.e1-432.e13.24 Ehrnhoefer DE, Bieschke J, Boeddrich A, et al.

EGCG redirects amyloidogenic polypeptides into

unstructured, off-pathway oligomers[J]. Nat Struct

Mol Biol, 2008, 15:558-566.

25 Rezai-Zadeh K, Shytle D, Sun N, et al. Green tea

epigallocatechin-3-gallate (EGCG) modulates

amyloid precursor protein cleavage and reduces

cerebral amyloidosis in Alzheimer transgenic mice[J].

J Neurosci, 2005, 25:8807-8814.

26 Lim GP, Chu T, Yang F, et al. The curry spice

curcumin reduces oxidative damage and amyloid

pathology in an Alzheimer transgenic mouse[J]. J

Neurosci, 2001, 21:8370-8377.

27 Hamaguchi T, Ono K, Murase A, et al. Phenolic

compounds prevent Alzheimer's pathology through

different effects on the amyloid-beta aggregation

pathway[J]. Am J Pathol, 2009, 175:2557-2265.

28 Liu KN, Lai CM, Lee YT, et al. Curcumin's preincubation

temperature affects its inhibitory potency

toward amyloid f ibrillation and f ibril-induced

cytotoxicity of lysozyme[J]. Biochim Biophys Acta,

2012, 1820:1774-1186.

29 Huang TC, LU KT, Wo YY, et al. Resverat rol

protects rats from Abeta-induced neurotoxicity

by the reduction of iNOS expression and lipid

peroxidation[J]. PLoS One, 2011, 6:e29102.

30 Ge JF, Qiao JP, Qi CC, et al. The binding of resveratrol

to monomer and fibril amyloid beta[J]. Neurochem Int,

2012, 61:1192-1201.

31 Feng Y, Wang XP, Yang SG, et al. Resveratrol inhibits

beta-amyloid oligomeric cytotoxicity but does not

prevent oligomer formation[J]. Neurotoxicology, 2009,

30:986-995.

32 Revesz T, Holton JL, Lashley T, et al. Genetics and

molecular pathogenesis of sporadic and hereditary

cerebral amyloid angiopathies[J]. Acta Neuropathol,

2009, 118:115-130.

33 Jiao SS, Yao XQ, Liu YH, et al. Edaravone alleviates

Alzheimer's disease-type pathologies and cognitive

deficits[J]. Proc Natl Acad Sci USA, 2015, 112:5225-

5230.

34 Mi l lucci L , Ghezzi L , Bermardini G, e t a l .

Conformations and biological activities of amyloid

beta peptide 25-35[J]. Curr Protein Pept Sci, 2010,

11:54-67.